Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Ossewaarde

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The Netherlands Journal of Medicine|July 31, 2001
Introducing Chlamydophila pneumoniae: the TWAR agent Chlamydia pneumoniae in a new perspectiveJ M Ossewaarde
Nederlands Tijdschrift Voor Geneeskunde|May 29, 1999
[Chlamydia pneumonia and atherosclerosis]J M Ossewaarde
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1989
Storage conditions of Chlamydia trachomatis antigensJ M Ossewaarde, M Rieffe
JAMA|April 13, 2001
Chlamydia trachomatis and cervical squamous cell carcinomaS A Morré, J M Ossewaarde
Drugs of Today (Barcelona, Spain : 1998)|May 10, 2006
Innate immunity in defense against Chlamydia trachomatis infectionsJ A Severin, J M Ossewaarde
Nederlands Tijdschrift Voor Geneeskunde|December 1, 1984
[Q fever infection probably caused by a human placenta]J M Ossewaarde, A C Hekker
Journal of Virological Methods|July 1, 1989
Development of a monoclonal antibody for use as an amboceptor in complement fixation testsJ M Ossewaarde, A D de Booij
Drugs of Today (Barcelona, Spain : 1998)|May 10, 2006
More than 25 years of urogenital Chlamydia trachomatis research in the NetherlandsServaas A Morré, Y Pannekoek, J M Ossewaarde
Applied Microbiology and Biotechnology|September 1, 1996
A microcarrier culture method for the production of large quantities of viable Chlamydia pneumoniaeA Meijer, C E Vallinga, J M Ossewaarde
Retina (Philadelphia, Pa.)|September 8, 1998
Bartonella serology for patients with intraocular inflammatory diseaseA Rothova, F Kerkhoff, H J Hooft, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The Netherlands Journal of Medicine|July 31, 2001
Introducing Chlamydophila pneumoniae: the TWAR agent Chlamydia pneumoniae in a new perspectiveJ M Ossewaarde
Nederlands Tijdschrift Voor Geneeskunde|May 29, 1999
[Chlamydia pneumonia and atherosclerosis]J M Ossewaarde
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1989
Storage conditions of Chlamydia trachomatis antigensJ M Ossewaarde, M Rieffe
JAMA|April 13, 2001
Chlamydia trachomatis and cervical squamous cell carcinomaS A Morré, J M Ossewaarde
Drugs of Today (Barcelona, Spain : 1998)|May 10, 2006
Innate immunity in defense against Chlamydia trachomatis infectionsJ A Severin, J M Ossewaarde
Nederlands Tijdschrift Voor Geneeskunde|December 1, 1984
[Q fever infection probably caused by a human placenta]J M Ossewaarde, A C Hekker
Journal of Virological Methods|July 1, 1989
Development of a monoclonal antibody for use as an amboceptor in complement fixation testsJ M Ossewaarde, A D de Booij
Drugs of Today (Barcelona, Spain : 1998)|May 10, 2006
More than 25 years of urogenital Chlamydia trachomatis research in the NetherlandsServaas A Morré, Y Pannekoek, J M Ossewaarde
Applied Microbiology and Biotechnology|September 1, 1996
A microcarrier culture method for the production of large quantities of viable Chlamydia pneumoniaeA Meijer, C E Vallinga, J M Ossewaarde
Retina (Philadelphia, Pa.)|September 8, 1998
Bartonella serology for patients with intraocular inflammatory diseaseA Rothova, F Kerkhoff, H J Hooft, et al.
Pageof 6